Trial intelligence / Profile preview

Low-dose Genotropin in HIV-infected Patients on HAART

NCT00119769Phase 4Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Feb 2005
Primary completion
May 2007
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 4 trial of somatropin in human immunodeficiency virus infection (HIV), HIV-associated lipodystrophy syndrome (HALS), sponsored by Copenhagen University Hospital - Hvidovre. Started Feb 2005; status: completed.

02

Drugs

somatropin
03

Conditions

human immunodeficiency virus infection (HIV)HIV-associated lipodystrophy syndrome (HALS)

Beyond the preview

Go deeper on NCT00119769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00119769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call